Home > Insider Trading > Filing (0001209191-17-056389)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
887151	Capstone Therapeutics Corp.	CAPS	Pharmaceutical Preparations (2834)	860585310

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
949119	Iii I Lloyd Miller	3300 South Dixie Highway Suite 1-365 West Palm Beach FL 33405		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-10-05	100,000	$0.06	624,100	No	4	S	Indirect	By LIMFAM LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By LIMFAM LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	472,792	Indirect	By Milfam II L.P.
Common Stock	90,344	Indirect	By Trust D - Lloyd I. Miller
Common Stock	641,218	Indirect	By Trust C - Lloyd I. Miller
Common Stock	2,914,484	Indirect	By LIM III - Trust A-4
Common Stock	2,914,484	Indirect	By MBM - Trust A-4

Footnotes

The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this filing.
On September 27, 2017, in accordance with that certain Exercise of Authority of Distribution Adviser of Trust A-4, dated as of August 10, 2017, pursuant to which all securities held by Trust A-4 - Lloyd I. Miller were decanted to two (2) newly formed trusts, the investment adviser to Trust A-4 - Lloyd I. Miller directed the trustee and distribution adviser to distribute fifty percent (50%) of such securities to LIM III - Trust A-4 and fifty percent (50%) of such securities to MBM - Trust A-4. The decanting and distribution of all securities held or formerly held by Trust A-4 - Lloyd I. Miller is in process and final consummation thereof has yet to occur. Such transactions, when consummated, only effect a change in the form of beneficial ownership without changing the reporting person's pecuniary interest in such securities and was (or will be) exempt from Section 16 of the Securities Exchange Act of 1934 pursuant to Rule 16a-13.